Introduction
Herpesviruses are well described causes of ocular disease, including retinitis and keratitis, in both immunocompetent and immunosuppressed patients. While cytomegalovirus (CMV) is the most frequent cause of retinitis in HIV infected patients,'-' varicella zoster virus (VZV) and herpes simplex type 1 (HSV-1) have been reported as causing necrotising herpetic retinopathy." Acute retinal necrosis (ARN) was first described in immunocompetent patients.67 Six years after this term was coined, Holland discussed the classification of a variety of clinical appearances of retinitis, all thought to be associated with herpes viruses, which were subsequently described in patients both with and without underlying immunosuppression such as AIDS. 7 Retinal necrosis secondary to herpes virus infection is recognised by multifocal and well demarcated whitening which begins in the peripheral areas of retina, becoming confluent and progressing both circumferentially and towards the centre. Patients with AIDS may lack the marked vitreous cell reaction and occlusive vasculopathy found in other patients and so the umbrella term necrotising herpetic retinopathy (NHR) is used to include a heterogeneous group of clinical descriptions, of which ARN and progressive outer retinal necrosis are subtypes.
Progressive outer retinal necrosis (PORN) is chiefly found in AIDS patients and is usually caused by VZV. It differs from ARN in having necrosis which underlies the retinal blood vessels within the deeper layers of retina, little vitreous inflammation, a notably more rapid progression, and a particularly poor prognosis for vision5 6 progressive, becoming confluent. Vitreal inflammation was scanty and vasculitis absent.5 6 At the time of their presentation all patients had been investigated using a unit protocol. Following ophthalmic assessment a magnetic resonance imaging (MRI) scan of the head was performed at 1.5 Tesla using a standard clinical system (Siemens Magnetom 63SP, Erlangen, Germany), and a lumbar puncture was carried out. In addition to routine microbiological and biochemical analysis an aliquot of CSF was used for the nested polymerase chain reaction (nPCR) for detection of VZV gene 29, CMV gB, HSV-1 gD, and HSV-2 gG sequences as previously described.80 12 13 In three patients a vitreous tap was also performed; this was subjected to nPCR for detection of herpesvirus DNA (as above).8-0 12 13 
Results
Of the five patients four were male (three white homosexuals and one heterosexual of African origin); the female was white and heterosexual. Their mean age was 34.5 years (range 31-41 years). Two patients had a previous AIDS defining diagnosis (Pneumocystis carinii pneumonia); three had no previous HIV associated problems. The median CD4 lymphocyte count was 20 x 106/1 (range 10-80 x 106/1); normal range 350-2200 X 106/1.
All patients reported loss of visual acuity; in Over the 28 month period of the study 66 new diagnoses of CMV retinitis were made in this centre.
Discussion
In this study we found that NHR is much less common than CMV retinitis in this group of HIV infected patients. All our patients presented with typical ocular abnormalities and in keeping with previous reports all our patients had advanced HIV disease and low CD4 lymphocyte counts,'4 15 although three had no previous HIV associated problems. Previous studies have commented on the strong associa-tion between NHR and antecedent cutaneous zoster infection. '6 17 Detection of VZV DNA in CSF of HIV infected patients with advanced disease and acute neurological presentations is an infrequent finding.9"1 In one prospective study of 120 HIV infected patients undergoing diagnostic lumbar puncture only eight (6.6%) had detectable VZV DNA. All eight, who had a range of neurological disease including VZV associated meningoencephalitis, transverse myelitis and encephalopathy, and CMV retinitis/encephalitis, had concurrent or a history of recent cutaneous zoster. 9 The infrequent detection of VZV DNA in CSF was also reported in a study of 500 patients from Milan, Italy.'" Seventy two patients were studied retrospectively and 428 were studied prospectively, all underwent diagnostic lumbar puncture for evaluation of clinical neurological disease. VZV DNA was detected in CSF of only 13 (3%). Only three of these 13 patients were clinically evaluable. One had presented with zoster ophthalmicus and subsequently developed a contralateral hemiparesis. The two others had recent shingles "a few weeks before presentation"; one had cryptococcal meningitis, and the other had "acute brain dysfunction". Necropsy, in these two patients and in two other non-evaluable patients, showed no evidence of VZV infection."
Detection of VZV DNA in ocular fluid in the absence of clinical evidence of NHR has not been reported. In one prospective study vitreous fluid samples were obtained from 100 patients, 50 of whom were HIV infected and had presented with retinitis and 50 who were not known to be HIV infected and were undergoing vitreoretinal procedures-for example, for diabetic retinopathy and retinal detachment.'0 There was no detectable VZV DNA in vitreous fluid from the 50 immunocompetent patients or from any of the HIV infected patients with CMV retinitis (n = 41), two of whom also had zoster ophthalmicus, ocular toxoplasmosis (n = 2), or ocular toxocara infection (n = 1). Detectable 
